This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
News|Articles|September 18, 2013
Columbia Laboratories Acquires Molecular Profiles
Author(s)Pharmaceutical Technology Editors
Columbia Laboratories acquires Molecular Profiles in multimillion-dollar deal.
Advertisement
This acquisition was unanimously approved by the boards of directors of both companies and received the approval of Molecular Profiles’ shareholders. No further approvals are anticipated to be required.
According to the company, Molecular Profiles’ recorded approximately $9 million in revenues for its fiscal year ended July 31, 2013.
Source:
Advertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
2
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
3
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
4
Choosing a Connected Product Technology for Anticounterfeiting
5